The Gabriella Miller Kids First Research Act (; ) is a law that ended taxpayer contributions to the Presidential Election Campaign Fund and authorized a pediatric research initiative through the National Institutes of Health. The total funding for research would come to $126 million over 10 years. At the time of its passage, national conventions drew about 23% of their funding from the Presidential Election Campaign Fund. It became law during the 113th United States Congress. Background Gabriella Miller of Leesburg, Virginia was a girl who died of diffuse intrinsic pontine glioma, a rare form of brain cancer on October 26, 2013 at the age of 10. While she was ill, she worked as an activist to raise support for research into childhood illnesses like cancer. Through her activism, she "raised hundreds of thousands of dollars for the Make-A-Wish Foundation and helped launch the Smashing Walnuts Foundation to fund pediatric cancer research." In "The Truth 365" documentary, Miller answered a question that what she'd like to tell American leaders about research on pediatric cancer was that there needed to be "less talking, more doing... We need action." House Majority Leader Eric Cantor saw this video and decided to name the bill in her honor. Provisions of the bill This summary is based largely on the summary provided by the Congressional Research Service, a public domain source. The Gabriella Miller Kids First Research Act would amend the Internal Revenue Code to terminate the entitlement of any major or minor political party to a payment from the Presidential Election Campaign Fund for a presidential nominating convention. The bill transfers funds in each account maintained for the national committee of a party to a 10-Year Pediatric Research Initiative Fund, making them available only for allocation to national research institutes and national centers through the Common Fund for making grants for pediatric research under this Act. The bill would amend the Public Health Service Act to require the Director of the National Institutes of Health (NIH), through the Division of Program Coordination, Planning, and Strategic Initiatives, to allocate funds appropriated under this Act to the national research institutes and national centers for making grants for pediatric research representing important areas of emerging scientific opportunities, rising public health challenges, or knowledge gaps that deserve special emphasis and would benefit from conducting or supporting additional research that involves collaboration between two or more national research institutes